Gradient Denervation Technologies
PrivateLast Round
Series A
Sep 7, 2023
Total Funding Raised
$19.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gradient Denervation Technologies is a medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gradient Denervation Technologies Comparables
Compare Gradient Denervation Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 88% | |
| Pulnovo Medical | 85% | |
| Otsuka Holdings | 70% | |
Gradient Denervation Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 7, 2023 | ||||
| Seed | Sep 17, 2020 |
Key People
Founding team and executive leadership
Gradient Denervation Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Thuja Capital | Series A |
| Sofinnova Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 4, 2.5x the trailing average.
- May 20, 2026
Grew 19% QoQ, from 16 to 19 employees.
Gradient Denervation Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gradient Denervation Technologies's valuation, stock price, and market status.